Literature DB >> 17280910

Radiotherapy for bladder cancer.

Michael Milosevic1, Mary Gospodarowicz, Anthony Zietman, Farhat Abbas, Karin Haustermans, Luc Moonen, Claus Rödel, Mark Schoenberg, William Shipley.   

Abstract

The radiotherapy panel met to develop international consensus about the optimal use of radiotherapy, alone or in combination with surgery and chemotherapy, in the radical treatment of patients with bladder cancer. A consensus meeting of experts in the treatment of bladder cancer was convened by the Société Internationale d'Urologie (SIU). The radiotherapy committee, which had international representation from 6 countries, performed a critical review of the English-language literature and developed evidence-based guidelines for the use of radiotherapy in the treatment of patients with bladder cancer. The strength of the evidence supporting each recommendation was ranked according to a 4-point scale. Consensus statements were developed that address (1) the effectiveness of radiotherapy in the treatment of bladder cancer, (2) the most appropriate patients for curative treatment with radiotherapy, (3) the optimal method of delivery of radiotherapy, (4) the best radiation prescription for treating bladder cancer, and (5) optimal management of the patient's condition after radiotherapy has been provided. Radiotherapy is effective treatment for selected patients with bladder cancer; it produces long-term disease control with preservation of normal bladder function. Modern radiotherapy treatment techniques offer the potential to improve cure rates and reduce adverse effects. All patients in whom the condition is newly diagnosed should be assessed in a multidisciplinary setting, where the relative merits of surgery, radiotherapy, and chemotherapy can be considered on an individual basis with the aim of optimizing overall outcomes.

Entities:  

Mesh:

Year:  2007        PMID: 17280910     DOI: 10.1016/j.urology.2006.05.060

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  19 in total

1.  Radical cystectomy is the treatment of choice for invasive bladder cancer.

Authors:  Faysal A Yafi; Wassim Kassouf
Journal:  Can Urol Assoc J       Date:  2009-10       Impact factor: 1.862

2.  Combination therapy: hypoxia modification with radiotherapy for bladder cancer.

Authors:  Mary Gospodarowicz
Journal:  Nat Rev Clin Oncol       Date:  2011-02-01       Impact factor: 66.675

3.  [Not Available].

Authors:  Christopher M Booth; D Robert Siemens
Journal:  Can Urol Assoc J       Date:  2014-09       Impact factor: 1.862

4.  Delivering high-quality care to patients with muscle-invasive bladder cancer: Insights from routine practice in Ontario.

Authors:  Christopher M Booth; D Robert Siemens
Journal:  Can Urol Assoc J       Date:  2014-09       Impact factor: 1.862

5.  Muscle-invasive bladder cancer organ-preserving therapy: systematic review and meta-analysis.

Authors:  Herney Andrés García-Perdomo; Carlos Eduardo Montes-Cardona; Marcela Guacheta; Diego Fernando Castillo; Leonardo O Reis
Journal:  World J Urol       Date:  2018-06-25       Impact factor: 4.226

6.  Carcinosarcoma of the bladder: case report and review of the literature.

Authors:  Arda Akoluk; Yagil Barazani; Denisa Slova; Sovrin Shah; Basir Tareen
Journal:  Can Urol Assoc J       Date:  2011-08       Impact factor: 1.862

7.  Expression of ribonucleoside reductase subunit M1, but not excision repair cross-complementation group 1, is predictive in muscle-invasive bladder cancer treated with chemotherapy and radiation.

Authors:  Mark Shilkrut; Angela Wu; Dafydd G Thomas; Daniel A Hamstra
Journal:  Mol Clin Oncol       Date:  2014-02-20

Review 8.  [Interdisciplinary strategies for the treatment of bladder cancer].

Authors:  Wilhelm Bauer; Michael Lamche; Paul Schramek
Journal:  Wien Med Wochenschr       Date:  2007

Review 9.  Contemporary management of muscle-invasive bladder cancer.

Authors:  Faysal A Yafi; Jordan R Steinberg; Wassim Kassouf
Journal:  Int J Clin Oncol       Date:  2008-12-18       Impact factor: 3.402

10.  Conservative treatment of invasive bladder cancer.

Authors:  N J Rene; F B Cury; L Souhami
Journal:  Curr Oncol       Date:  2009-08       Impact factor: 3.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.